Tissue Regenix Group plc (TRX) Ordinary 0.5p
Share news, reports & tips
15 August 2019 09:59
(Sharecast News) - Regenerative medical devices company Tissue Regenix Group has signed a 10-year lease agreement on a 21,000 square foot facility, it announced on Thursday, to expand processing capacity at...
4 April 2019 16:28
(Sharecast News) - Tissue Regenix Group on Thursday secured additional coverage with a US Group Purchasing Organization (GPO) for the use of DermaPure, a chronic wound treatment product.
4 February 2019 11:52
(Sharecast News) - Medical devices company Tissue Regenix expects to breakeven in 2020 after seeing revenues more than double in its last trading year.
6 December 2018 12:51
(Sharecast News) - The chief executive officer of Tissue Regenix, Steve Couldwell, will be taking a leave of absence from the start of the next year as he undergoes medical treatment.
13 November 2018 11:52
(Sharecast News) - Tissue Regenix's subsidiary CellRight Technologies on Tuesday entered an agreement to allow Arthrex to distribute its proprietary 'BioRinse' bone portfolio throughout Europe.
25 June 2018 09:53
(Sharecast News) - Regenerative medical devices company Tissue Regenix Group has been granted a Human Tissue Authority (HTA) license to import and distribute its portfolio of human tissue derived products...
24 April 2018 09:21
(WebFG News) - Regenerative medical devices company Tissue Regenix Group announced on Tuesday that, following the successful completion of the manufacturing technical transfer, it has begun sales of...
26 February 2018 10:19
(ShareCast News) - Regenerative medical devices company Tissue Regenix Group announced the launch of a new operating division on Monday - 'TRX BioSurgery'.
2 November 2017 15:23
(ShareCast News) - Regenerative medical devices company Tissue Regenix Group announced the appointment of Steve Couldwell as its chief executive officer on Thursday, effective immediately.
12 October 2016 14:03
(ShareCast News) - AIM-listed regenerative medical devices company Tissue Regenix Group's saw operating losses widen at the interim stage even as its revenues nudged higher, although it did gain...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2019. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.